HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

VIP-ELP fusion molecule PB1046

Also Known As:

PB1046; vasoactive intestinal peptide elastin-like polypeptides

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Macromolecular Substances: 97
- Polymers: 13051
  - Biopolymers: 773
    - Elastin: 3083
      - Elastin-Like Polypeptides: 76
        VIP-ELP fusion molecule PB1046: 1
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
- Peptides: 82426
  - Neuropeptides: 6772
    - Vasoactive Intestinal Peptide: 2100
      - VIP-ELP fusion molecule PB1046: 1
  - Peptide Hormones: 1347
    - Vasoactive Intestinal Peptide: 2100
      - VIP-ELP fusion molecule PB1046: 1
Pharmaceutical Preparations
- Dosage Forms: 1139
  - Drug Carriers: 2375
    - Elastin-Like Polypeptides: 76
      - VIP-ELP fusion molecule PB1046: 1
Therapeutics: 1158551
- Drug Therapy: 293145
  - Drug Delivery Systems
    - Drug Carriers: 2375
      - Elastin-Like Polypeptides: 76
        VIP-ELP fusion molecule PB1046: 1
Hormones, Hormone Substitutes, and Hormone Antagonists
- Hormones: 80400
  - Peptide Hormones: 1347
    - Vasoactive Intestinal Peptide: 2100
      - VIP-ELP fusion molecule PB1046: 1
  - Gastrointestinal Hormones: 573
    - Vasoactive Intestinal Peptide: 2100
      - VIP-ELP fusion molecule PB1046: 1

Experts

1.	Paulis, Ludovit: 1 article (06/2015)
2.	Rajkovicova, Romana: 1 article (06/2015)
3.	Simko, Fedor: 1 article (06/2015)

Related Diseases

1.

Hypertension (High Blood Pressure)

06/01/2015 - "The new possible approaches to combat high blood pressure include neprilysin/neutral endopeptidase (NEP) inhibition, particularly when combined with an angiotensin receptor blockade (such as the ARNI, LCZ696), phosphodiesterase 5 (PDE5) inhibition (KD027/Slx-2101), natriuretic agents (PL3994), or a long-lasting vasointestinal peptide (VIP) analogue (PB1046). "

Related Drugs and Biologics

1.	Type 5 Cyclic Nucleotide Phosphodiesterases
2.	Natriuretic Agents
3.	Neprilysin (Neutral Endopeptidase)
4.	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
5.	Angiotensin Receptors (Angiotensin II Receptor)
6.	sacubitril and valsartan sodium hydrate drug combination